BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Year-over-year gross profit growth rate
3Y CAGR
+7.7%/yr
Annual compound
Percentile
P79
Within normal range
vs 3Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 95.28% |
| 2024 | 34.12% |
| 2023 | 23.66% |
| 2022 | 76.27% |
| 2021 | 829.02% |
| 2020 | -63.93% |
| 2019 | 121.65% |
| 2018 | -14.06% |
| 2017 | -0.72% |
| 2016 | -48.98% |